FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frank Zemlan

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Brooke E Schmeichel; Frank P Zemlan; Craig W Berridge
A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
S Prasad Gabbita; Nigel H Greig; Pirooz Eslami; Ming F Johnson; Naomi K Kobritz; Sherven P Sharma; Minu K Srivastava; David Tweedie; Frank P Zemlan; Marni E Harris-White
Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.
Marek Ma; Christopher J Lindsell; Clark M Rosenberry; George J Shaw; Frank P Zemlan
Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frank Zemlan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brooke E Schmeichel; Frank P Zemlan; Craig W Berridge
A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
Neuropharmacology 2013;64():321-8.
2012: S Prasad Gabbita; Nigel H Greig; Pirooz Eslami; Ming F Johnson; Naomi K Kobritz; Sherven P Sharma; Minu K Srivastava; David Tweedie; Frank P Zemlan; Marni E Harris-White
Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.
Journal of neuroinflammation 2012;9():99.
2008: Marek Ma; Christopher J Lindsell; Clark M Rosenberry; George J Shaw; Frank P Zemlan
Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury.
The American journal of emergency medicine 2008;26(7):763-8.
2007: M M W Straiko; Lique M Coolen; Frank P Zemlan; Gary A Gudelsky
The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain.
Neuroscience 2007;144(1):223-31.
2006: M M W Straiko; Gary A Gudelsky; Lique M Coolen; R Harrison; Frank P Zemlan
Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain.
Journal of neuroscience research 2006;84(5):1116-23.
2006: Jeffrey J Bazarian; Frank P Zemlan; Sohug Mookerjee; stigbrand torgny
Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury.
Brain injury : [BI] 2006;20(7):759-65.
2005: Frank P Zemlan; J Jeffery Mulchahey; Martin B Scharf; David W Mayleben; Russell Rosenberg; Alan Lankford
The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
The Journal of clinical psychiatry 2005;66(3):384-90.
2005: S Prasad Gabbita; Stephen W Scheff; Renee M Menard; Kelly Roberts; Isabella Fugaccia; Frank P Zemlan
Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury.
Journal of neurotrauma 2005;22(1):83-94.
2005: Jose Irazuzta; Robert K Pretzlaff; Gabrielle DeCourten-Myers; Frank P Zemlan; Basilia Zingarelli
Dexamethasone decreases neurological sequelae and caspase activity.
Intensive care medicine 2005;31(1):146-50.
2004: Melinda West; Molina Mhatre; Alex Ceballos; Robert A Floyd; Paula Grammas; S Prasad Gabbita; Ladan Hamdheydari; Tammy Mai; Shenyun Mou; Quentin N Pye; Charles Stewart; Stuart West; Kelly S Williamson; Frank P Zemlan; Kenneth Hensley
The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice.
Journal of neurochemistry 2004;91(1):133-43.
2004: J Jeffery Mulchahey; D R Goldwater; Frank P Zemlan
A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog beta-methyl-6-chloromelatonin.
Life sciences 2004;75(15):1843-56.
2003: Frank P Zemlan; J Jeffery Mulchahey; Gary A Gudelsky
Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-tau (C-tau).
Neuroscience 2003;121(2):399-409.
2003: Tanya L Wallace; Charles V Vorhees; Frank P Zemlan; Gary A Gudelsky
Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain.
Neuroscience 2003;116(4):1063-8.
2002: Jose Irazuzta; Robert K Pretzlaff; Basilia Zingarelli; Vivian Xue; Frank P Zemlan
Modulation of nuclear factor-kappaB activation and decreased markers of neurological injury associated with hypothermic therapy in experimental bacterial meningitis.
Critical care medicine 2002;30(11):2553-9.
2002: Frank P Zemlan; Edward Jauch; J Jeffery Mulchahey; S Prasad Gabbita; William S Rosenberg; Samuel G Speciale; Mario Zuccarello
C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.
Brain research 2002;947(1):131-9.
2002: George J Shaw; Edward Jauch; Frank P Zemlan
Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury.
Annals of emergency medicine 2002;39(3):254-7.
2001: Jose Irazuzta; G de Courten-Myers; Frank P Zemlan; Marni Bekkedal; John Rossi
Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis.
Brain research 2001;913(1):95-105.
2000: Jose Irazuzta; Robert K Pretzlaff; ME Rowin; K Milam; Frank P Zemlan; Basilia Zingarelli
Hypothermia as an adjunctive treatment for severe bacterial meningitis.
Brain research 2000;881(1):88-97.
1999: Frank P Zemlan; W S Rosenberg; P A Luebbe; T A Campbell; Gary E Dean; N E Weiner; J A Cohen; R A Rudick; D Woo
Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.
Journal of neurochemistry 1999;72(2):741-50.
1998: Xinkang Wang; P Luebbe; Eric I Gruenstein; Frank P Zemlan
Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways.
Journal of neuroscience research 1998;51(5):658-65.
1997: L McLaughlin; Frank P Zemlan; Gary E Dean
Identification of microtubule-associated protein tau isoforms in Alzheimer's paired helical filaments.
Brain research bulletin 1997;43(5):501-8.
1996: Frank P Zemlan; Gary E Dean
Monoclonal antibody PHF-9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments.
Journal of neuroscience research 1996;46(1):90-7.
1994: Frank P Zemlan; Anne Z Murphy; Michael M Behbehani
5-HT1A receptors mediate the effect of the bulbospinal serotonin system on spinal dorsal horn nociceptive neurons.
Pharmacology 1994;48(1):1-10.
1994: Frank P Zemlan; G D Vogelsang; L McLaughlin; Gary E Dean
Alzheimer's paired helical filaments: amyloid precursor protein epitope mapping.
Brain research bulletin 1994;33(4):387-92.
1992: R M Murphy; Frank P Zemlan
Quantitative autoradiographic mapping of a novel serotonin receptor-5-HT1S.
Neuroreport 1992;3(10):837-40.
1992: Anne Z Murphy; R M Murphy; Frank P Zemlan
Role of spinal serotonin1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes.
Psychopharmacology 1992;108(1-2):123-30.
1991: Frank P Zemlan; E F Schwab
Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
Journal of neurochemistry 1991;57(6):2092-9.
1990: R M Murphy; Frank P Zemlan
Selective serotonin1A/1B agonists differentially affect spinal nociceptive reflexes.
Neuropharmacology 1990;29(5):463-8.
1990: O J Thienhaus; J Thoene; A Allen; Frank P Zemlan
[Plasma anticholinergic activity and cognitive function in geriatric patients].
Psychiatrie, Neurologie, und medizinische Psychologie 1990;42(5):275-81.
1990: Michael M Behbehani; Frank P Zemlan
Bulbospinal and intraspinal thyrotropin releasing hormone systems: modulation of spinal cord pain transmission.
Neuropeptides 1990;15(3):161-8.
1990: Frank P Zemlan; A Zieleniewski-Murphy; R Maureen Murphy; Michael M Behbehani
BMY 7378: Partial agonist at spinal cord 5-HT(1A) receptors.
Neurochemistry international 1990;16(4):515-22.
1990: Frank P Zemlan; E F Schwab; R Maureen Murphy; Michael M Behbehani
Identification of a novel 5-HT(1) binding site in rat spinal cord.
Neurochemistry international 1990;16(4):507-13.
1990: Frank P Zemlan; O J Thienhaus; D L Garver
Length of psychiatric hospitalization and prediction of antipsychotic response.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(1):13-24.
1990: G D Vogelsang; Frank P Zemlan; Gary E Dean
Purification and solubilization of paired helical filaments from Alzheimer brains.
Journal of neurochemistry 1990;54(1):148-55.
1990: Frank P Zemlan; D L Garver
Depression and antidepressant therapy: receptor dynamics.
Progress in neuro-psychopharmacology & biological psychiatry 1990;14(4):503-23.
1990: O J Thienhaus; A Allen; J A Bennett; Y M Chopra; Frank P Zemlan
Anticholinergic serum levels and cognitive performance.
European archives of psychiatry and clinical neuroscience 1990;240(1):28-33.
1989: Frank P Zemlan; O J Thienhaus; H B Bosmann
Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation.
Brain research 1989;476(1):160-2.
1989: G D Vogelsang; Frank P Zemlan; Gary E Dean
Hyperpurification of paired helical filaments reveals elevations in hydroxyproline content and a core structure related peptide fragment.
Progress in clinical and biological research 1989;317():791-800.
1989: R M Murphy; Frank P Zemlan
Functional change in the 5-HT presynaptic receptor in spinal cord of aged rats.
Neurobiology of aging 1989;10(1):95-7.
1988: Frank P Zemlan; Michael M Behbehani
Nucleus cuneiformis and pain modulation: anatomy and behavioral pharmacology.
Brain research 1988;453(1-2):89-102.
1988: R M Murphy; Frank P Zemlan
Selective 5-HT1B agonists identify the 5-HT autoreceptor in lumbar spinal cord of rat.
Neuropharmacology 1988;27(1):37-42.
1987: R M Murphy; Frank P Zemlan
Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes.
Psychopharmacology 1987;93(1):118-21.
1986: Michael M Behbehani; Frank P Zemlan
Response of nucleus raphe magnus neurons to electrical stimulation of nucleus cuneiformis: role of acetylcholine.
Brain research 1986;369(1-2):110-8.
1984: Frank P Zemlan; Michael M Behbehani
Afferent projections to the nucleus cuneiformis in the rat.
Neuroscience letters 1984;52(1-2):103-9.
1984: Frank P Zemlan; Michael M Behbehani; R M Beckstead
Ascending and descending projections from nucleus reticularis magnocellularis and nucleus reticularis gigantocellularis: an autoradiographic and horseradish peroxidase study in the rat.
Brain research 1984;292(2):207-20.